Clinton Wu

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 8

Top Topics

Stem Cell Transplantation

Coronary Artery Bypass

Radiation Induced

Top Venues

International journal of molecular sciences

Journal of hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Junaid Arshad, Amith Rao, Matthew L Repp, Rohit Rao, Clinton Wu, Juanita L Merchant
Myeloid-Derived Suppressor Cells: Therapeutic Target for Gastrointestinal Cancers. International journal of molecular sciences 25 (5) (2024)
Clinton Wu, Paulina Kuzmin, Ricklie Julian
De-Escalation Strategies in HPV-Associated Oropharynx Cancer: A Historical Perspective with Future Direction. Cancers 16 (15) (2024)
Clinton Wu, Paulina Kuzmin, Ricklie Julian
De-Escalation Strategies in HPV-Associated Oropharynx Cancer: A Historical Perspective with Future Direction. Cancers 16 (15) (2024)
Junaid Arshad, Amith Rao, Matthew L Repp, Rohit Rao, Clinton Wu, Juanita L Merchant
Myeloid-Derived Suppressor Cells: Therapeutic Target for Gastrointestinal Cancers. International journal of molecular sciences 25 (5) (2024)
Junaid Arshad, Amith Rao, Matthew L Repp, Rohit Rao, Clinton Wu, Juanita L Merchant
Myeloid-Derived Suppressor Cells: Therapeutic Target for Gastrointestinal Cancers. International journal of molecular sciences 25 (5) (2024)
Junaid Arshad, Amith Rao, Matthew L Repp, Rohit Rao, Clinton Wu, Juanita L Merchant
Myeloid-Derived Suppressor Cells: Therapeutic Target for Gastrointestinal Cancers. International journal of molecular sciences 25 (5) (2024)
Clinton Wu, Pete Manchen, Ariela Edelman, Muhammad Husnain, Emmanuel Katsanis, Deborah Fuchs, Laura Stephens, Sharad Khurana
Refractory Pure Red Blood Cell Aplasia Secondary to Major ABO-Incompatible Allogeneic Stem Cell Transplantation Successfully Treated With Daratumumab. Journal of hematology 12 (6) (2023)
Clinton Wu, Pete Manchen, Ariela Edelman, Muhammad Husnain, Emmanuel Katsanis, Deborah Fuchs, Laura Stephens, Sharad Khurana
Refractory Pure Red Blood Cell Aplasia Secondary to Major ABO-Incompatible Allogeneic Stem Cell Transplantation Successfully Treated With Daratumumab. Journal of hematology 12 (6) (2023)